Pharmaceutical Technology | Drug Development News & Views …
Pharmaceutical news and in-depth feature articles on the new drug discoveries, healthcare research and development, big pharma trends and company deals.
Pharma breakthroughs: 10 novel drug approvals that made …
Dec 20, 2023 · Pharma breakthroughs: 10 novel drug approvals that made headlines in 2023 Pharmaceutical Technology outlines some of the biggest US Food and Drug Administration (FDA) drug approvals announced in 2023 that are set to make an impact in the coming years.
ADCs breach barriers to become mainstream cancer treatment
Dec 17, 2024 · The antibody-drug conjugate (ADC) manufacturing landscape offers the potential to leverage significant opportunities for cancer treatment, but faces complex challenges. Nevertheless, the ADC market potential is significant, with one estimate by CAS, a division of the American Chemical Society ...
How technology could transform drug research in 2022
Dec 14, 2021 · When we think of new technologies in medicine, we tend to conjure images of futuristic AI computers, 3D-printed organs, and robot surgeons.The ambitious and lesser-explored methods currently being applied in drug discovery and development, however, could prove to be just as exciting.. A GlobalData survey this year revealed that over 70% of pharma industry respondents anticipate drug ...
Pharma developments in 2022: what you need to know
Jan 5, 2022 · Pharma: the big picture. While artificial intelligence and robotics continue to gain popularity in the pharma lexicon, Darcy Jimenez took a closer look at more specific ways in which technology can influence drug development research.In a separate article, Manasi Vaidya discovers that, fueled by the successful use of mRNA vaccines in Covid-19, RNA therapeutics are expected to make larger ...
Pfizer's colorectal cancer combo gains FDA accelerated approval
5 days ago · Pfizer has gained accelerated approval from the US Food and Drug Administration (FDA) for BRAFTOVI (encorafenib) in conjunction with cetuximab and mFOLFOX6 for treating metastatic colorectal cancer (mCRC) with a BRAF V600E mutation, confirmed by an FDA-approved test.. This decision follows a significant improvement in response rate and durability response observed in the treatment-naïve ...
Pharmaceutical Technology’s most-read stories of 2023
Dec 19, 2023 · As the year comes to a close, we at Pharmaceutical Technology take stock at some of the biggest headlines of the year. One of the most popular stories on the site was a forward-looking feature that outlined the biggest expected catalysts involving CRISPR gene therapies and posited 2023 as the milestone year for this approach. The interest in this cutting edge technology was unsurprising given ...
Digital transformation expected to shorten drug development …
Nov 27, 2024 · Commenting on the results Urte Jakimaviciute, senior director of market research and strategic intelligence at GlobalData, said: “Survey findings highlight that the growing recognition within the pharmaceutical industry that technology, particularly AI, is accelerating innovation and efficiency in the drug discovery and development process, enabling processes such as faster identification of ...
Artificial Intelligence in Pharma: Innovations, Patents, and Trends
Aug 20, 2024 · Discover how pharmaceutical companies are leveraging AI patents to enhance drug development processes, improve research efficiency, and drive innovation in the industry. Explore diverse applications and strategic deals in the pharmaceutical industry. Get insights on AI hiring trends and the countries leading AI adoption. Read more.
Cell and gene therapy approvals drive paradigm change in …
Oct 14, 2024 · From early phase to commercialisation, cell and gene therapies introduce a range of unique challenges – from the complexities of running a patient-centric rare disease trial and the importance of extended follow-up periods for monitoring patient safety and efficacy to the significant cost of treatments and the critical need to demonstrate strong value …